Hold Biocon 320-put option as stock may drop to ₹350, with potential for premium increase. Contact [email protected] ...

Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement.

Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.

Nifty 50, India’s benchmark index, closed 92 points higher on Tuesday, ending its two-day losing streak to settle at ...

Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...

MUMBAI: Indian shares rose on Tuesday, led by a rally in energy stocks after a brokerage upgraded ONGC and as Reliance recovered some of its losses from the previous session. The Nifty 50 gained 0.39% ...

Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...

Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with ...

Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, ...

Biocon's biosimilar Ustekinumab receives regulatory approval in Japan, with Yoshindo Inc. handling commercialization and ...